Skip to main content
Erschienen in: Endocrine 3/2015

01.12.2015 | Original Article

Predictive value of intratumoral heterogeneity of F-18 FDG uptake for characterization of thyroid nodules according to Bethesda categories of fine needle aspiration biopsy results

verfasst von: Seong-Jang Kim, Samuel Chang

Erschienen in: Endocrine | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

The current study was aimed to investigate the clinical value of intratumoral heterogeneity of F-18 FDG uptake for characterization of thyroid nodule (TN) with inconclusive fine-needle aspiration biopsy (FNAB) results. The current study enrolled 200 patients who showed F-18 FDG incidentaloma and were performed FNAB. The intratumoral heterogeneity of F-18 FDG uptake was represented as the heterogeneity factor (HF), defined as the derivative (dV/dT) of a volume-threshold function for a primary tumor. The diagnostic and predictive values of HF and F-18 FDG PET/CT parameters were evaluated for characterization of inconclusive FNAB results. Among F-18 FDG PET/CT parameters, SUVmax, MTV, and TLG of malignant group were statistically higher than those of Bethesda category of suspicious malignant group. However, HF values were not statistically different between the groups of Bethesda categories (Kruskal–Wallis statistics, 9.924; p = 0.0774). In ROC analysis, when HF > 2.751 was used as cut-off value, the sensitivity and specificity for prediction of malignant TN were 100 % (95 % CI 69.2–100 %) and 60 % (95 % CI 42.1–76.1 %), respectively. The AUC was 0.826 (95 % CI 0.684–0.922) and standard error was 0.0648 (p < 0.0001). In conclusion, the intratumoral heterogeneity of F-18 FDG uptake represented by HF could be a predictor for characterization of TN with inconclusive FNAB results. Additional large population-based prospective studies are needed to validate the diagnostic utility of HF of F-18 FDG PET/CT.
Literatur
1.
Zurück zum Zitat C. Hambleton, E. Kandil, Appropriate and accurate diagnosis of thyroid nodule: a review of thyroid fine-needle aspiration. Int. J. Clin. Exp. Med. 6, 413–422 (2013)PubMedCentralPubMed C. Hambleton, E. Kandil, Appropriate and accurate diagnosis of thyroid nodule: a review of thyroid fine-needle aspiration. Int. J. Clin. Exp. Med. 6, 413–422 (2013)PubMedCentralPubMed
2.
Zurück zum Zitat M. Goldfarb, S. Gondek, C. Soloranzo, J.I. Lew, Surgeon-performed ultrasound can predict benignity in thyroid nodules. Surgery 50, 436–441 (2011)CrossRef M. Goldfarb, S. Gondek, C. Soloranzo, J.I. Lew, Surgeon-performed ultrasound can predict benignity in thyroid nodules. Surgery 50, 436–441 (2011)CrossRef
3.
Zurück zum Zitat D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, S.J. Mandel, E.L. Mazzaferri, B. McIver, F. Pacini, M. Schlumberger, S.I. Sherman, D.L. Steward, R.M. Tuttle, Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19, 1167–1214 (2009)CrossRefPubMed D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, S.J. Mandel, E.L. Mazzaferri, B. McIver, F. Pacini, M. Schlumberger, S.I. Sherman, D.L. Steward, R.M. Tuttle, Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19, 1167–1214 (2009)CrossRefPubMed
4.
5.
Zurück zum Zitat J.R. Porterfield Jr, C.S. Grant, D.S. Dean, G.B. Thompson, D.R. Farley, M.L. Richards, C.C. Reading, J.W. Charboneau, B.K. Vollrath, T.J. Sebo, Reliability of benign fine needle aspiration cytology of large thyroid nodules. Surgery 144, 963–968 (2008)CrossRefPubMed J.R. Porterfield Jr, C.S. Grant, D.S. Dean, G.B. Thompson, D.R. Farley, M.L. Richards, C.C. Reading, J.W. Charboneau, B.K. Vollrath, T.J. Sebo, Reliability of benign fine needle aspiration cytology of large thyroid nodules. Surgery 144, 963–968 (2008)CrossRefPubMed
6.
Zurück zum Zitat J.B. Ogilvie, E.J. Piatigorsky, O.H. Clark, Current status of fine needle aspiration for thyroid nodules. Adv. Surg. 40, 223–238 (2006)CrossRefPubMed J.B. Ogilvie, E.J. Piatigorsky, O.H. Clark, Current status of fine needle aspiration for thyroid nodules. Adv. Surg. 40, 223–238 (2006)CrossRefPubMed
7.
Zurück zum Zitat E.S. Cibas, S.Z. Ali, NCI Thyroid FNA State of the Science Conference, The Bethesda system for reporting thyroid cytopathology. Am. J. Clin. Pathol. 132, 658–665 (2009)CrossRefPubMed E.S. Cibas, S.Z. Ali, NCI Thyroid FNA State of the Science Conference, The Bethesda system for reporting thyroid cytopathology. Am. J. Clin. Pathol. 132, 658–665 (2009)CrossRefPubMed
8.
Zurück zum Zitat S. Rorive, N. D’Haene, C. Fossion, I. Delpierre, N. Abarguia, F. Avni, C. Decaestecker, I. Salmon, Ultrasound-guided fine-needle aspiration of thyroid nodules: stratification of malignancy risk using follicular proliferation grading, clinical and ultrasonographic features. Eur. J. Endocrinol. 162, 1107–1115 (2010)CrossRefPubMed S. Rorive, N. D’Haene, C. Fossion, I. Delpierre, N. Abarguia, F. Avni, C. Decaestecker, I. Salmon, Ultrasound-guided fine-needle aspiration of thyroid nodules: stratification of malignancy risk using follicular proliferation grading, clinical and ultrasonographic features. Eur. J. Endocrinol. 162, 1107–1115 (2010)CrossRefPubMed
9.
Zurück zum Zitat L.J. Layfield, E.S. Cibas, H. Gharib, S.J. Mandel, Thyroid aspiration cytology: current status. CA Cancer J. Clin. 59, 99–110 (2009)CrossRefPubMed L.J. Layfield, E.S. Cibas, H. Gharib, S.J. Mandel, Thyroid aspiration cytology: current status. CA Cancer J. Clin. 59, 99–110 (2009)CrossRefPubMed
10.
Zurück zum Zitat G.H. Heppner, Tumor heterogeneity. Cancer Res. 44, 2259–2265 (1984)PubMed G.H. Heppner, Tumor heterogeneity. Cancer Res. 44, 2259–2265 (1984)PubMed
11.
12.
Zurück zum Zitat M.E. Lleonart, P. Martin-Duque, R. Sanchez-Prieto, A. Moreno, S. Cajal, Tumor heterogeneity: morphological, molecular and clinical implications. Histol. Histopathol. 15, 881–889 (2000)PubMed M.E. Lleonart, P. Martin-Duque, R. Sanchez-Prieto, A. Moreno, S. Cajal, Tumor heterogeneity: morphological, molecular and clinical implications. Histol. Histopathol. 15, 881–889 (2000)PubMed
13.
Zurück zum Zitat B. Huang, T. Chan, D.L. Kwong, W.K. Chan, P.L. Khong, Nasopharyngeal carcinoma: investigation of intratumoral heterogeneity with FDG PET/CT. AJR Am. J. Roentgenol. 199, 169–174 (2012)CrossRefPubMed B. Huang, T. Chan, D.L. Kwong, W.K. Chan, P.L. Khong, Nasopharyngeal carcinoma: investigation of intratumoral heterogeneity with FDG PET/CT. AJR Am. J. Roentgenol. 199, 169–174 (2012)CrossRefPubMed
14.
Zurück zum Zitat F. Tixier, C.C. Le Rest, M. Hatt, N. Albarghach, O. Pradier, Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predict response to concomitant radiochemotherapy in esophageal cancer. J. Nucl. Med. 52, 369–378 (2011)PubMedCentralCrossRefPubMed F. Tixier, C.C. Le Rest, M. Hatt, N. Albarghach, O. Pradier, Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predict response to concomitant radiochemotherapy in esophageal cancer. J. Nucl. Med. 52, 369–378 (2011)PubMedCentralCrossRefPubMed
15.
Zurück zum Zitat G.J. Cook, C. Yip, M. Siddique, V. Goh, S. Chicklore, A. Roy, P. Marsden, S. Ahmad, D. Landau, Are pretreatment 18F-FDG PET tumor textural features in non-small cell lung cancer associated with response and survival after chemoradiotherapy? J. Nucl. Med. 54, 19–26 (2013)CrossRefPubMed G.J. Cook, C. Yip, M. Siddique, V. Goh, S. Chicklore, A. Roy, P. Marsden, S. Ahmad, D. Landau, Are pretreatment 18F-FDG PET tumor textural features in non-small cell lung cancer associated with response and survival after chemoradiotherapy? J. Nucl. Med. 54, 19–26 (2013)CrossRefPubMed
16.
Zurück zum Zitat S.H. Son, D.H. Kim, C.M. Hong, C.Y. Kim, S.Y. Jeong, S.W. Lee, J. Lee, B.C. Ahn, Prognostic implication of intratumoral metabolic heterogeneity in invasive ductal carcinoma of the breast. BMC Cancer 14, 585–595 (2014)PubMedCentralCrossRefPubMed S.H. Son, D.H. Kim, C.M. Hong, C.Y. Kim, S.Y. Jeong, S.W. Lee, J. Lee, B.C. Ahn, Prognostic implication of intratumoral metabolic heterogeneity in invasive ductal carcinoma of the breast. BMC Cancer 14, 585–595 (2014)PubMedCentralCrossRefPubMed
17.
Zurück zum Zitat E.A. Kidd, P.W. Grigsby, Intratumoral metabolic heterogeneity of cervical cancer. Clin. Cancer Res. 14, 5236–5241 (2008)CrossRefPubMed E.A. Kidd, P.W. Grigsby, Intratumoral metabolic heterogeneity of cervical cancer. Clin. Cancer Res. 14, 5236–5241 (2008)CrossRefPubMed
18.
Zurück zum Zitat T.R. Miller, P.W. Grigsby, Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 53, 353–359 (2002)CrossRefPubMed T.R. Miller, P.W. Grigsby, Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 53, 353–359 (2002)CrossRefPubMed
19.
Zurück zum Zitat M. Soret, S.L. Bachrach, I. Buvat, Partial volume effect in PET tumor imaging. J. Nucl. Med. 48, 932–945 (2007)CrossRefPubMed M. Soret, S.L. Bachrach, I. Buvat, Partial volume effect in PET tumor imaging. J. Nucl. Med. 48, 932–945 (2007)CrossRefPubMed
20.
Zurück zum Zitat R. Siegel, D. Naishadham, A. Jemal, Cancer statistics, 2012. CA Cancer J. Clin. 62, 10–29 (2012)CrossRefPubMed R. Siegel, D. Naishadham, A. Jemal, Cancer statistics, 2012. CA Cancer J. Clin. 62, 10–29 (2012)CrossRefPubMed
21.
Zurück zum Zitat J.A. Sipos, E.L. Mazzaferri, Thyroid cancer epidemiology and prognostic variables. Clin. Oncol. (R. Coll. Radiol.) 22, 395–404 (2010)CrossRef J.A. Sipos, E.L. Mazzaferri, Thyroid cancer epidemiology and prognostic variables. Clin. Oncol. (R. Coll. Radiol.) 22, 395–404 (2010)CrossRef
22.
Zurück zum Zitat B. Miller, S. Burkey, G. Lindberg, W.H. Snyder 3rd, F.E. Nwariaku, Prevalence of malignancy within cytologically indeterminate thyroid nodules. Am. J. Surg. 188, 459–462 (2004)CrossRefPubMed B. Miller, S. Burkey, G. Lindberg, W.H. Snyder 3rd, F.E. Nwariaku, Prevalence of malignancy within cytologically indeterminate thyroid nodules. Am. J. Surg. 188, 459–462 (2004)CrossRefPubMed
23.
Zurück zum Zitat G.M. Scabas, G.A. Staerkel, S.E. Shapiro, Fine-needle aspiration of the thyroid and correlation with hispathology in a contemporary series of 240 patients. Am. J. Surg. 186, 702–710 (2003)CrossRef G.M. Scabas, G.A. Staerkel, S.E. Shapiro, Fine-needle aspiration of the thyroid and correlation with hispathology in a contemporary series of 240 patients. Am. J. Surg. 186, 702–710 (2003)CrossRef
24.
Zurück zum Zitat S.M. Khoncarly, S.W. Tamarkin, C.R. McHenry, Can ultrasound be used to predict malignancy in patients with a thyroid nodule and an indeterminate fine-needle aspiration biopsy ? Surgery 156, 967–971 (2014)CrossRefPubMed S.M. Khoncarly, S.W. Tamarkin, C.R. McHenry, Can ultrasound be used to predict malignancy in patients with a thyroid nodule and an indeterminate fine-needle aspiration biopsy ? Surgery 156, 967–971 (2014)CrossRefPubMed
25.
Zurück zum Zitat N. Batawil, T. Alkordy, Ultrasonographic features associated with malignancy in cytologically indeterminate thyroid nodules. EJSO 40, 182–186 (2014)CrossRefPubMed N. Batawil, T. Alkordy, Ultrasonographic features associated with malignancy in cytologically indeterminate thyroid nodules. EJSO 40, 182–186 (2014)CrossRefPubMed
26.
Zurück zum Zitat H. Li, K.A. Robinson, B. Anton, I.J. Saldanha, P.W. Ladenson, Cost-effectiveness of a novel molecular test for cytologically indeterminate thyroid nodules. J. Clin. Endocrinol. Metab. 96, E1719–E1726 (2011)CrossRefPubMed H. Li, K.A. Robinson, B. Anton, I.J. Saldanha, P.W. Ladenson, Cost-effectiveness of a novel molecular test for cytologically indeterminate thyroid nodules. J. Clin. Endocrinol. Metab. 96, E1719–E1726 (2011)CrossRefPubMed
27.
Zurück zum Zitat Y.E. Nikiforov, N.P. Ohori, S.P. Hodak, S.E. Carty, S.O. LeBeau, R.L. Ferris, L. Yip, R.R. Seethala, M.E. Tublin, M.T. Stang, C. Coyne, J.T. Johnson, A.F. Stewart, M.N. Nikiforova, Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J. Clin. Endocrinol. Metab. 96, 3390–3397 (2011)PubMedCentralCrossRefPubMed Y.E. Nikiforov, N.P. Ohori, S.P. Hodak, S.E. Carty, S.O. LeBeau, R.L. Ferris, L. Yip, R.R. Seethala, M.E. Tublin, M.T. Stang, C. Coyne, J.T. Johnson, A.F. Stewart, M.N. Nikiforova, Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J. Clin. Endocrinol. Metab. 96, 3390–3397 (2011)PubMedCentralCrossRefPubMed
28.
Zurück zum Zitat D. Vriens, E.M. Adang, R.T. Netea-Maier, J.W. Smit, J.H. de Wilt, W.J. Oyen, L.F. de Geus-Oei, Cost-effectiveness of FDG-PET/CT for cytologically indeterminate thyroid nodules: a decision analytic approach. J. Clin. Endocrinol. Metab. 99, 3263–3274 (2014)CrossRefPubMed D. Vriens, E.M. Adang, R.T. Netea-Maier, J.W. Smit, J.H. de Wilt, W.J. Oyen, L.F. de Geus-Oei, Cost-effectiveness of FDG-PET/CT for cytologically indeterminate thyroid nodules: a decision analytic approach. J. Clin. Endocrinol. Metab. 99, 3263–3274 (2014)CrossRefPubMed
29.
Zurück zum Zitat A.L. Traugott, F. Dehdashti, K. Trinkaus, M. Cohen, E. Fialkowski, F. Quayle, H. Hussain, R. Davila, L. Ylagan, J.F. Moley, Exclusion of malignancy in thyroid nodules with indeterminate fine-needle aspiration cytology after negative 18 F-fluorodeoxyglucose positron emission tomography: interim analysis. World J. Surg. 34, 1247–1253 (2010)PubMedCentralCrossRefPubMed A.L. Traugott, F. Dehdashti, K. Trinkaus, M. Cohen, E. Fialkowski, F. Quayle, H. Hussain, R. Davila, L. Ylagan, J.F. Moley, Exclusion of malignancy in thyroid nodules with indeterminate fine-needle aspiration cytology after negative 18 F-fluorodeoxyglucose positron emission tomography: interim analysis. World J. Surg. 34, 1247–1253 (2010)PubMedCentralCrossRefPubMed
30.
Zurück zum Zitat D. Deandreis, A. Al Ghuzlan, A. Auperin, P. Vielh, B. Caillou, L. Chami, J. Lumbroso, J.P. Travagli, D. Hartl, E. Baudin, M. Schlumberger, S. Leboulleux, Is (18)F-fluorodeoxyglucose-PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology? Thyroid 22, 165–172 (2012)CrossRefPubMed D. Deandreis, A. Al Ghuzlan, A. Auperin, P. Vielh, B. Caillou, L. Chami, J. Lumbroso, J.P. Travagli, D. Hartl, E. Baudin, M. Schlumberger, S. Leboulleux, Is (18)F-fluorodeoxyglucose-PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology? Thyroid 22, 165–172 (2012)CrossRefPubMed
31.
Zurück zum Zitat J.M. Kim, J.S. Ryu, T.Y. Kim, W.B. Kim, G.Y. Kwon, G. Gong, D.H. Moon, S.C. Kim, S.J. Hong, Y.K. Shong, 18F-fluorodeoxyglucose positron emission tomography does not predict malignancy in thyroid nodules cytologically diagnosed as follicular neoplasm. J. Clin. Endocrinol. Metab. 92, 1630–1634 (2007)CrossRefPubMed J.M. Kim, J.S. Ryu, T.Y. Kim, W.B. Kim, G.Y. Kwon, G. Gong, D.H. Moon, S.C. Kim, S.J. Hong, Y.K. Shong, 18F-fluorodeoxyglucose positron emission tomography does not predict malignancy in thyroid nodules cytologically diagnosed as follicular neoplasm. J. Clin. Endocrinol. Metab. 92, 1630–1634 (2007)CrossRefPubMed
32.
Zurück zum Zitat N.W. Hales, G.A. Krempl, J.E. Medina, Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules? Am. J. Otolaryngol. 29, 113–118 (2008)CrossRefPubMed N.W. Hales, G.A. Krempl, J.E. Medina, Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules? Am. J. Otolaryngol. 29, 113–118 (2008)CrossRefPubMed
33.
Zurück zum Zitat N. Wang, H. Zhai, Y. Lu, Is fluorine-18 fluorodeoxyglucose positron emission tomography useful for the thyroid nodules with indeterminate fine needle aspiration biopsy? A meta-analysis of the literature. J. Otolaryngol. Head Neck Surg. 42, 38 (2013). doi:10.1186/1916-0216-42-38 PubMedCentralCrossRefPubMed N. Wang, H. Zhai, Y. Lu, Is fluorine-18 fluorodeoxyglucose positron emission tomography useful for the thyroid nodules with indeterminate fine needle aspiration biopsy? A meta-analysis of the literature. J. Otolaryngol. Head Neck Surg. 42, 38 (2013). doi:10.​1186/​1916-0216-42-38 PubMedCentralCrossRefPubMed
34.
Zurück zum Zitat D. Vriens, J.H. de Wilt, G.J. van der Wilt, R.T. Netea-Maier, W.J. Oyen, L.F. de Geus-Oei, The role of [18F]-2-fluoro-2-deoxy-d-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: systematic review and meta-analysis of the literature. Cancer 117, 4582–4594 (2011)CrossRefPubMed D. Vriens, J.H. de Wilt, G.J. van der Wilt, R.T. Netea-Maier, W.J. Oyen, L.F. de Geus-Oei, The role of [18F]-2-fluoro-2-deoxy-d-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: systematic review and meta-analysis of the literature. Cancer 117, 4582–4594 (2011)CrossRefPubMed
35.
Zurück zum Zitat S.H. Kwon, J.K. Yoon, Y.S. An, Y.S. Shin, C.H. Kim, D.H. Lee, K.S. Jo, S.J. Lee, Prognostic significance of the intratumoral heterogeneity of (18) F-FDG uptake in oral cavity cancer. J. Surg. Oncol. 110, 702–706 (2014)CrossRefPubMed S.H. Kwon, J.K. Yoon, Y.S. An, Y.S. Shin, C.H. Kim, D.H. Lee, K.S. Jo, S.J. Lee, Prognostic significance of the intratumoral heterogeneity of (18) F-FDG uptake in oral cavity cancer. J. Surg. Oncol. 110, 702–706 (2014)CrossRefPubMed
Metadaten
Titel
Predictive value of intratumoral heterogeneity of F-18 FDG uptake for characterization of thyroid nodules according to Bethesda categories of fine needle aspiration biopsy results
verfasst von
Seong-Jang Kim
Samuel Chang
Publikationsdatum
01.12.2015
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 3/2015
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-015-0620-z

Weitere Artikel der Ausgabe 3/2015

Endocrine 3/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.